Welcome to LookChem.com Sign In|Join Free
  • or
1H-1,4,7-Triazonine, 1,1'-[1,3-phenylenebis(methylene)]bis[octahydro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

189033-35-0

Post Buying Request

189033-35-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

189033-35-0 Usage

Chemical structure

The compound contains a triazonine ring and a phenylenebis(methylene) group.

Explanation

The triazonine ring is a six-membered heterocyclic ring with three nitrogen atoms, while the phenylenebis(methylene) group consists of a central phenyl ring with two methylene groups attached.

Explanation

Organic compounds are primarily made up of carbon and hydrogen atoms, and 1H-1,4,7-Triazonine, 1,1'-[1,3-phenylenebis(methylene)]bis[octahydro- is no exception.

Explanation

The unique structure and properties of 1H-1,4,7-Triazonine, 1,1'-[1,3-phenylenebis(methylene)]bis[octahydro- make it a candidate for use in the development of new materials and pharmaceuticals.

Explanation

A heterocyclic ring is a ring of atoms containing at least one non-carbon and non-hydrogen atom, in this case, nitrogen.

Explanation

The presence of nitrogen atoms in the triazonine ring contributes to the compound's unique properties.

Explanation

The phenyl ring is a six-carbon aromatic ring with alternating single and double bonds, which is a common structural element in many organic compounds.

Explanation

The combination of the triazonine ring and the phenylenebis(methylene) group results in a compound with distinct characteristics that may be useful in various applications.

Explanation

The unique structure and properties of the compound make it a candidate for use in creating innovative materials with specific characteristics.

Explanation

The compound's unique properties may be harnessed to create new drugs or improve existing ones, contributing to advancements in the pharmaceutical industry.

Organic compound

It is an organic compound.

Potential applications

Pharmaceutical and material science.

Heterocyclic ring

The triazonine ring is a six-membered heterocyclic ring.

Nitrogen atoms

The triazonine ring contains three nitrogen atoms.

Central phenyl ring

The phenylenebis(methylene) group has a central phenyl ring.

Methylene groups

The phenylenebis(methylene) group has two methylene groups attached.

Unique properties

The compound is known for its unique properties.

Development of new materials

The compound has potential applications in the development of new materials.

Pharmaceutical development

The compound has potential applications in the development of new pharmaceuticals.

Check Digit Verification of cas no

The CAS Registry Mumber 189033-35-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,0,3 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 189033-35:
(8*1)+(7*8)+(6*9)+(5*0)+(4*3)+(3*3)+(2*3)+(1*5)=150
150 % 10 = 0
So 189033-35-0 is a valid CAS Registry Number.

189033-35-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[[3-(1,4,7-triazonan-1-ylmethyl)phenyl]methyl]-1,4,7-triazonane

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:189033-35-0 SDS

189033-35-0Downstream Products

189033-35-0Relevant academic research and scientific papers

Synthesis of a series of novel binucleating ligands based on 1,4,7-triazacyclononane and o-, m- and p-xylene: Crystal structure of the μ-hydroxy-bridged dicopper(II) complex [Cu2Lm(OH)2][BPh4]2 [Lm = α,α′-bis(N-1,4,7-triazacyclononane)-m-xylene]

Farrugia, Louis J.,Lovatt, Paul A.,Peacock, Robert D.

, p. 911 - 912 (1997)

The crystal structure and magnetic properties of [Cu2Lm(OH)2][BPh4]2 has been determined; Lm is one of three new binucleating ligands based on 1,4,7-triazacyclononane and o-, m- or p-xylene.

Dinuclear Fe(III) Hydroxypropyl-Appended Macrocyclic Complexes as MRI Probes

Asik, Didar,Abozeid, Samira M.,Turowski, Steven G.,Spernyak, Joseph A.,Morrow, Janet R.

, p. 8651 - 8664 (2021)

Four high-spin Fe(III) macrocyclic complexes, including three dinuclear and one mononuclear complex, were prepared toward the development of more effective iron-based magnetic resonance imaging (MRI) contrast agents. All four complexes contain a 1,4,7-triazacyclononane macrocyclic backbone with two hydroxypropyl pendant groups, an ancillary aryl or biphenyl group, and a coordination site for a water ligand. The pH potentiometric titrations support one or two deprotonations of the complexes, most likely deprotonation of hydroxypropyl groups at near-neutral pH. Variable-temperature 17O NMR studies suggest that the inner-sphere water ligand is slow to exchange with bulk water on the NMR time scale. Water proton T1 relaxation times measured for solutions of the Fe(III) complexes at pH 7.2 showed that the dinuclear complexes have a 2- to 3-fold increase in r1 relaxivity in comparison to the mononuclear complex per molecule at field strengths ranging from 1.4 T to 9.4 T. The most effective agent, a dinuclear complex with macrocycles linked through para-substitution of an aryl group (Fe2(PARA)), has an r1 of 6.7 mM-1 s-1 at 37 °C and 4.7 T or 3.3 mM-1 s-1 per iron center in the presence of serum albumin and shows enhanced blood pool and kidney contrast in mice MRI studies.

COMPOUNDS FOR USE AS IRON (III) MRI CONTRAST AGENTS CONTAINING ANIONIC PENDENTS AND ANCILLARY GROUPS

-

Paragraph 0141, (2020/06/05)

Macrocyclic complexes and macrocyclic compounds. The macrocyclic complexes or macrocyclic compounds have a TACN moiety with one or more amine group(s) or a O- or S- substituted TACN moiety. The macrocyclic complexes have a high-spin Fe(III) atom coordinated to the TACN moiety. The macrocyclic complexes can be used in imaging methods.

COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS

-

, (2018/12/12)

Provided are macrocyclic compounds and compounds with two or more macrocyclic groups, iron coordinated macrocyclic compounds, and iron coordinated compounds with two or more macrocyclic groups. The iron is high-spin iron(III). The iron coordinated compoun

Using iSUSTAIN to validate the chemical attributes of different approaches to the synthesis of tacn and bridged (bis)tacn ligands

Coghlan,Campi,Jackson,Hearn

, p. 5477 - 5484 (2016/10/21)

Using green chemistry principles, alternative approaches for the synthesis of commercially important aza-macrocyclic tacn and (bis)tacn derivatives have been investigated to determine the step average and overall efficiency of these synthetic methods. Based on analytical metrics derived from the iSUSTAIN toolkit, the Richman-Atkins route for the synthesis of tacn (1) was found to be the more efficient; however an alternate route was shown to be preferable for the synthesis of (bis)tacn (2) compounds. The outcome of this study documents the importance of rigorous analysis of synthetic procedures for such aza-macrocyclic compounds in terms of their green chemistry attributes, in order to delineate how alternative synthetic methods can be ranked, more innovative procedures selected to improve productivity and yield, and synthetic methods deployed to achieve greater levels of waste reduction, reduced use of hazardous chemicals and lower environmental impact.

Dinuclear copper(II) complexes that promote hydrolysis of GpppG, a model for the 5′-cap of mRNA

McCue, Kevin P.,Voss Jr., David A.,Marks, Christian,Morrow, Janet R.

, p. 2961 - 2963 (2007/10/03)

The hydrolysis of the monoribonucleotide GpppG, a model compound for the 5′-cap structure of mRNA, by dinuclear Cu(II) complexes of triazacyclononane was 100-fold more rapid than in the presense of the analogous mononuclear complex; a first-order or second-order dependence on the catalyst was observed for two different dinuclear complexes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 189033-35-0